Every Promea product is developed in-house. Our research teams in Hyderabad and Vietnam manage the complete development cycle, from concept to commercial product.
With more than 25 years of biopharmaceutical research experience, our scientists have successfully developed over 50 products across multiple therapeutic areas and dosage forms.
This depth of expertise gives us full ownership of our technology and a thorough understanding of every product we manufacture.
Our principal research centre, located in one of the world's leading pharmaceutical hubs, where new products are conceived, formulated and validated.
Development laboratories integrated within our manufacturing campus, enabling close collaboration between research and production teams.
Oral solid and sterile injectable oncology therapies.
Injectable and infusion therapies for hospital and critical care.
Biological therapies for serious, chronic and life-threatening conditions.
Point-of-care diagnostic solutions that support clinical decision-making.